{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:06:15Z","timestamp":1793639175737,"version":"4.5.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["FWF P 21904-B11"],"award-info":[{"award-number":["FWF P 21904-B11"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00109-018-1641-x","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T19:00:24Z","timestamp":1525719624000},"page":"559-573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Selective inhibition of receptor activator of NF-\u03baB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction"],"prefix":"10.1007","volume":"96","author":[{"given":"Svetlana","family":"Slavic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Andrukhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Handschuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nejla","family":"Latic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Reichart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soleman","family":"Sasgary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bergow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz C.","family":"Hofbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Kostenuik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0801-6958","authenticated-orcid":false,"given":"Reinhold G.","family":"Erben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"1641_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1161\/CIRCOUTCOMES.110.957803","volume":"3","author":"WJ Kostis","year":"2010","unstructured":"Kostis WJ, Deng Y, Pantazopoulos JS, Moreyra AE, Kostis JB, for the Myocardial Infarction Data Acquisition System (MIDAS14) Study Group (2010) Trends in mortality of acute myocardial infarction after discharge from the hospital. Circ Cardiovasc Qual Outcomes 3:581\u2013589","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1641_CR2","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1161\/CIRCOUTCOMES.110.959163","volume":"3","author":"VL Roger","year":"2010","unstructured":"Roger VL (2010) Myocardial infarction outcomes: \u201cthe times, they are a-changin...\u201d. Circ Cardiovasc Qual Outcomes 3:568\u2013570","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1641_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165\u2013176","journal-title":"Cell"},{"key":"1641_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1161\/CIRCULATIONAHA.106.686774","volume":"116","author":"S Kiechl","year":"2007","unstructured":"Kiechl S, Schett G, Schwaiger J, Seppi K, Eder P, Egger G, Santer P, Mayr A, Xu Q, Willeit J (2007) Soluble receptor activator of nuclear factor-kappa B ligand and risk for cardiovascular disease. Circulation 116:385\u2013391","journal-title":"Circulation"},{"key":"1641_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1161\/01.ATV.0000204334.48195.6a","volume":"26","author":"WJ Sandberg","year":"2006","unstructured":"Sandberg WJ, Yndestad A, \u00d8ie E et al (2006) Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization. Arterioscler Thromb Vasc Biol 26:857\u2013863","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1641_CR6","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","volume":"12","author":"N Bucay","year":"1998","unstructured":"Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260\u20131268","journal-title":"Genes Dev"},{"key":"1641_CR7","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1161\/01.CIR.0000165119.62099.14","volume":"111","author":"T Ueland","year":"2005","unstructured":"Ueland T, Yndestad A, \u00d8ie E, Florholmen G, Halvorsen B, Fr\u00f8land SS, Simonsen S, Christensen G, Gullestad L, Aukrust P (2005) Dysregulated osteoprotegerin\/RANK ligand\/RANK axis in clinical and experimental heart failure. Circulation 111:2461\u20132468","journal-title":"Circulation"},{"key":"1641_CR8","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","volume":"108","author":"JW Gordon","year":"2011","unstructured":"Gordon JW, Shaw JA, Kirshenbaum LA (2011) Multiple facets of NF-\u03baB in the heart: to be or not to NF-\u03baB. Circ Res 108:1122\u20131132","journal-title":"Circ Res"},{"key":"1641_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/cvr\/cvs078","volume":"94","author":"S Ock","year":"2012","unstructured":"Ock S, Ahn J, Lee SH, Park H, Son JW, Oh JG, Yang DK, Lee WS, Kim HS, Rho J, Oh GT, Abel ED, Park WJ, Min JK, Kim J (2012) Receptor activator of nuclear factor-B ligand is a novel inducer of myocardial inflammation. Cardiovasc Res 94:105\u2013114","journal-title":"Cardiovasc Res"},{"key":"1641_CR10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nm.3084","volume":"19","author":"S Kiechl","year":"2013","unstructured":"Kiechl S, Wittmann J, Giaccari A, Knoflach M, Willeit P, Bozec A, Moschen AR, Muscogiuri G, Sorice GP, Kireva T, Summerer M, Wirtz S, Luther J, Mielenz D, Billmeier U, Egger G, Mayr A, Oberhollenzer F, Kronenberg F, Orthofer M, Penninger JM, Meigs JB, Bonora E, Tilg H, Willeit J, Schett G (2013) Blockade of receptor activator of nuclear factor-\u03baB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat Med 19:358\u2013363","journal-title":"Nat Med"},{"key":"1641_CR11","doi-asserted-by":"publisher","first-page":"8191","DOI":"10.1073\/pnas.1400544111","volume":"111","author":"M Shimamura","year":"2014","unstructured":"Shimamura M, Nakagami H, Osako MK, Kurinami H, Koriyama H, Zhengda P, Tomioka H, Tenma A, Wakayama K, Morishita R (2014) OPG\/RANKL\/RANK axis is a critical inflammatory signaling system in ischemic brain in mice. Proc Natl Acad Sci U S A 111:8191\u20138196","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1641_CR12","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/hep.24756","volume":"55","author":"N Sakai","year":"2012","unstructured":"Sakai N, Van Sweringen HL, Schuster R et al (2012) Receptor activator of nuclear factor-\u03baB ligand (RANKL) protects against hepatic ischemia\/reperfusion injury in mice. Hepatology 55:888\u2013897","journal-title":"Hepatology"},{"key":"1641_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1359\/jbmr.081112","volume":"24","author":"PJ Kostenuik","year":"2009","unstructured":"Kostenuik PJ, Nguyen HQ, McCabe J, Warmington KS, Kurahara C, Sun N, Chen C, Li L, Cattley RC, van G, Scully S, Elliott R, Grisanti M, Morony S, Tan HL, Asuncion F, Li X, Ominsky MS, Stolina M, Dwyer D, Dougall WC, Hawkins N, Boyle WJ, Simonet WS, Sullivan JK (2009) Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL. J Bone Miner Res Off J Am Soc Bone Miner Res 24:182\u2013195","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"1641_CR14","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1111\/j.1582-4934.2010.01216.x","volume":"15","author":"KI Od\u00f6rfer","year":"2011","unstructured":"Od\u00f6rfer KI, Egerbacher M, Unger NJ, Weber K, Jamnig A, Lepperdinger G, Kleiter M, Sandgren EP, Erben RG (2011) Hematopoietic bone marrow cells participate in endothelial, but not epithelial or mesenchymal cell renewal in adult rats. J Cell Mol Med 15:2232\u20132244","journal-title":"J Cell Mol Med"},{"key":"1641_CR15","doi-asserted-by":"publisher","first-page":"6460","DOI":"10.1038\/s41598-017-06614-0","volume":"7","author":"C Streicher","year":"2017","unstructured":"Streicher C, Heyny A, Andrukhova O, Haigl B, Slavic S, Sch\u00fcler C, Kollmann K, Kantner I, Sexl V, Kleiter M, Hofbauer LC, Kostenuik PJ, Erben RG (2017) Estrogen regulates bone turnover by targeting RANKL expression in bone lining cells. Sci Rep 7:6460","journal-title":"Sci Rep"},{"key":"1641_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.yjmcc.2016.03.013","volume":"94","author":"F Carbone","year":"2016","unstructured":"Carbone F, Crowe LA, Roth A, Burger F, Lenglet S, Braunersreuther V, Brandt KJ, Quercioli A, Mach F, Vall\u00e9e JP, Montecucco F (2016) Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury. J Mol Cell Cardiol 94:82\u201394","journal-title":"J Mol Cell Cardiol"},{"key":"1641_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/36593","volume":"390","author":"DM Anderson","year":"1997","unstructured":"Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175\u2013179","journal-title":"Nature"},{"key":"1641_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"YY Kong","year":"1999","unstructured":"Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315\u2013323","journal-title":"Nature"},{"key":"1641_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nm1417","volume":"12","author":"O Kollet","year":"2006","unstructured":"Kollet O, Dar A, Shivtiel S, Kalinkovich A, Lapid K, Sztainberg Y, Tesio M, Samstein RM, Goichberg P, Spiegel A, Elson A, Lapidot T (2006) Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 12:657\u2013664","journal-title":"Nat Med"},{"key":"1641_CR20","first-page":"557","volume":"26","author":"K-A Cho","year":"2010","unstructured":"Cho K-A, Joo S-Y, Han H-S, Ryu KH, Woo SY (2010) Osteoclast activation by receptor activator of NF-kappaB ligand enhances the mobilization of hematopoietic progenitor cells from the bone marrow in acute injury. Int J Mol Med 26:557\u2013563","journal-title":"Int J Mol Med"},{"key":"1641_CR21","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.4049\/jimmunol.177.6.3799","volume":"177","author":"K Maruyama","year":"2006","unstructured":"Maruyama K, Takada Y, Ray N et al (2006) Receptor activator of NF-kappa B ligand and osteoprotegerin regulate proinflammatory cytokine production in mice. J Immunol (Baltimore, Md 1950) 177:3799\u20133805","journal-title":"J Immunol (Baltimore, Md 1950)"},{"key":"1641_CR22","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/nm1518","volume":"12","author":"K Loser","year":"2006","unstructured":"Loser K, Mehling A, Loeser S, Apelt J, Kuhn A, Grabbe S, Schwarz T, Penninger JM, Beissert S (2006) Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 12:1372\u20131379","journal-title":"Nat Med"},{"key":"1641_CR23","doi-asserted-by":"publisher","unstructured":"Sager HB, Heidt T, Hulsmans M, Dutta P, Courties G, Sebas M, Wojtkiewicz GR, Tricot B, Iwamoto Y, Sun Y et al (2015) Targeting interleukin-1\u03b2 reduces leukocyte production after acute myocardial infarction. Circulation. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.016160","DOI":"10.1161\/CIRCULATIONAHA.115.016160"},{"key":"1641_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2353\/ajpath.2008.070974","volume":"173","author":"M Bujak","year":"2008","unstructured":"Bujak M, Dobaczewski M, Chatila K, Mendoza LH, Li N, Reddy A, Frangogiannis NG (2008) Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol 173:57\u201367","journal-title":"Am J Pathol"},{"key":"1641_CR25","doi-asserted-by":"publisher","first-page":"21896","DOI":"10.1074\/jbc.M114.549642","volume":"289","author":"N Khoury El","year":"2014","unstructured":"El Khoury N, Mathieu S, Fiset C (2014) Interleukin-1\u03b2 reduces L-type Ca2+ current through protein kinase C\u03f5 activation in mouse heart. J Biol Chem 289:21896\u201321908","journal-title":"J Biol Chem"},{"key":"1641_CR26","doi-asserted-by":"publisher","first-page":"6753","DOI":"10.1073\/pnas.86.17.6753","volume":"86","author":"T Gulick","year":"1989","unstructured":"Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF (1989) Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci U S A 86:6753\u20136757","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1641_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1160\/TH11-05-0324","volume":"107","author":"A Quercioli","year":"2012","unstructured":"Quercioli A, Mach F, Bertolotto M, Lenglet S, Vuilleumier N, Galan K, Pagano S, Braunersreuther V, Pelli G, Pistoia V, Bianchi G, Cittadini G, Viviani GL, Pende A, Roux-Lombard P, Thomas A, Staub C, Ratib O, Dallegri F, Schindler TH, Montecucco F (2012) Receptor activator of NF-\u03baB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability. Thromb Haemost 107:124\u2013139","journal-title":"Thromb Haemost"},{"key":"1641_CR28","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","volume":"96","author":"H Hsu","year":"1999","unstructured":"Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A 96:3540\u20133545","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1641_CR29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/cmi.2013.39","volume":"10","author":"JK Antonios","year":"2013","unstructured":"Antonios JK, Yao Z, Li C, Rao AJ, Goodman SB (2013) Macrophage polarization in response to wear particles in vitro. Cell Mol Immunol 10:471\u2013482","journal-title":"Cell Mol Immunol"},{"key":"1641_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1126\/science.1230719","volume":"339","author":"FK Swirski","year":"2013","unstructured":"Swirski FK, Nahrendorf M (2013) Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339:161\u2013166","journal-title":"Science"},{"key":"1641_CR31","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, Martin JS, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765","journal-title":"N Engl J Med"},{"key":"1641_CR32","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1182\/blood-2006-04-016600","volume":"108","author":"M Ogawa","year":"2006","unstructured":"Ogawa M, LaRue AC, Drake CJ (2006) Hematopoietic origin of fibroblasts\/myofibroblasts: its pathophysiologic implications. Blood 108:2893\u20132896","journal-title":"Blood"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-018-1641-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-018-1641-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-018-1641-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T19:34:00Z","timestamp":1557257640000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-018-1641-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["1641"],"URL":"https:\/\/doi.org\/10.1007\/s00109-018-1641-x","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"assertion":[{"value":"18 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were undertaken in accordance with current guidelines for animal care and welfare and were approved by the Ethical Committees of the University of Veterinary Medicine Vienna and of the Austrian Federal Ministry of Science, Research and Economy.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"PJK is a former Amgen employee who owns Amgen stock and serves as a consultant and contract medical writer for Amgen. The other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}